Enveric Biosciences, Inc.
ENVB
$1.65
$0.053.13%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -8.22M | -8.77M | -9.73M | -9.94M | -9.30M |
| Total Depreciation and Amortization | 157.10K | 200.90K | 243.90K | 288.30K | 333.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 642.60K | 725.60K | 1.34M | 1.65M | 1.80M |
| Change in Net Operating Assets | -586.00K | -296.00K | 481.20K | 1.48M | -345.30K |
| Cash from Operations | -8.01M | -8.14M | -7.67M | -6.52M | -7.52M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 8.63M | 10.58M | 8.37M | 5.90M | 5.52M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -20.40K | -20.50K | -50.60K |
| Cash from Financing | 8.63M | 10.58M | 8.35M | 5.88M | 5.46M |
| Foreign Exchange rate Adjustments | -12.70K | -1.50K | -39.70K | -11.60K | -6.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 614.40K | 2.44M | 645.90K | -652.80K | -2.06M |